ACCUZIDE

This brand name is authorized in Austria, Germany, Estonia, Lithuania, Romania, Turkey

Active ingredients

The drug ACCUZIDE contains a combination of these active pharmaceutical ingredients (APIs):

1 Quinapril UNII 33067B3N2M - QUINAPRIL HYDROCHLORIDE

Quinapril is a potent angiotensin-converting enzyme (ACE) inhibitor. The mode of action of quinapril in humans and animals is to inhibit circulating and tissue ACE activity, thereby decreasing vasopressor activity and aldosterone secretion. Read about Quinapril

2 Hydrochlorothiazide UNII 0J48LPH2TH - HYDROCHLOROTHIAZIDE

Hydrochlorothiazide is a diuretic with antihypertensive properties. It acts by inhibiting the renal tubular re-absorption of sodium and chloride ions, which are excreted with an accompanying volume of water. Potassium excretion is also promoted. Read about Hydrochlorothiazide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C09BA06	Quinapril and diuretics	C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09B ACE inhibitors, combinations → C09BA ACE inhibitors and diuretics
Discover more medicines within C09BA06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00923236, 04627836, 04627865
Country: EE	Ravimiamet	Identifier(s): 1030105, 1031094, 1074934
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1003974, 1003975, 1004178, 1004180, 1019930, 1057643, 1057644, 1082463
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64843001, W64844001, W64845001
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8681308091123, 8681308091185